文献速递疼痛医学

慢性疼痛植入装置相关医疗法律索赔分析

A Contemporary Medicolegal Analysis of Implanted Devices for Chronic Pain Management.
PubMed 文献 · Anesth Analg · 2017-01-01

该研究分析了2009至2013年疼痛医学的闭合索赔案例,识别出17例鞘内药物输注系统(IDDS)和11例脊髓电刺激(SCS)索赔。损伤事件包括IDDS再填充错误、术中神经损伤和术后感染,技术技能不足是最常见原因。研究强调提供者培训、患者选择和沟通的重要性。

要点

  • IDDS和SCS植入存在显著并发症风险,包括神经损伤和死亡。
  • 技术技能不足是导致损伤的最常见因素。
  • 需加强提供者培训、患者选择及并发症沟通。

核心结论

  • 用于疼痛管理的植入装置涉及显著的发病和死亡风险,适当的教育和培训至关重要。

主要发现

  • IDDS相关闭合索赔17例,SCS相关11例。
  • 最常见慢性疼痛诊断为失败背部手术综合征和痉挛。
  • 疼痛医学索赔平均总费用为166,028美元。
  • 损伤事件包括IDDS再填充错误(如皮下给药、重编程错误)、术中神经损伤和术后感染(如硬膜外脓肿、脑膜炎)。
  • 高严重度结局包括神经损伤(如截瘫)和死亡;中严重度结局包括药物反应(如阿片过量致呼吸停止)和需再手术。

临床怎么用

  • 提供者应掌握植入和再填充所需的技术技能,以及识别和管理并发症(如鞘内肉芽肿)的临床技能。
  • 应注重患者选择,并与患者清晰沟通可能并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Analysis of closed malpractice claims allows the study of rare but serious complications and likely results in improved patient safety by raising awareness of such complications. Clinical studies and closed claims analyses have previously reported on the common complications associated with intrathecal drug delivery systems (IDDS) and spinal cord stimulators (SCS). This study provides a contemporary analysis of claims from within the past 10 years. METHODS: We performed a closed claims analysis for a period January 1, 2009 to December 31, 2013 for cases with pain medicine as the primary service. These cases were identified using the Controlled Risk Insurance Company (CRICO) Comparative Benchmarking System (CBS), a database containing more than 300,000 malpractice claims from more than 400 academic and community institutions, representing approximately 30% of malpractice cases in the United States. The clinical narratives, which included medical files, claims files, depositions, and expert witness testimony, were reviewed by the authors, as were the CRICO coded variables, which included algorithmically determined contributing factors to the patient injury. RESULTS: Intrathecal drug delivery systems represented 17 of the closed claims; spinal cord stimulators represented 11 of the closed claims. The most common chronic pain diagnoses for which a device was implanted included failed back surgery syndrome and spasticity. The average total incurred for pain medicine claims was $166,028. Damaging events included IDDS refill errors (eg, subcutaneous administration of medication, reprogramming errors), intraoperative nerve damage, and postoperative infection (eg, epidural abscess, meningitis). High-severity outcomes included nerve damage (eg, paraplegia) and death. Medium-severity outcomes included drug reactions (eg, respiratory arrest from opioid overdose) and the need for reoperation. For both IDDS and SCS, deficits in technical skill were the most common contributing factor to injury, followed by deficits in clinical judgment, communication, and documentation. CONCLUSIONS: Implanted devices used for pain management involve a significant risk of morbidity and mortality. Proper education of providers and patients is essential. Providers must acquire the technical skills required for the implantation and refilling of these devices and the clinical skills required for the identification and management of complications such as intrathecal granuloma. Proper patient selection and clear communication between the provider and the patient about these possible complications are of paramount importance.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Abrecht CR, Greenberg P, Song E, et al. A Contemporary Medicolegal Analysis of Implanted Devices for Chronic Pain Management. Anesth Analg. 2017. PMID: 28319551. doi:10.1213/ANE.0000000000001702

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。